Collectively, these results validate the utility of FGFR-agonist as an effective substitute or supplement for bFGF in the formation and maintenance of neurospheres, providing compelling evidence that FGFR-agonist can emulate the biological roles of bFGF in regulating NPC behavior and promoting neurosphere development. This evidence concerns the gene FGF2 and nasopharyngeal carcinoma.